A Family Portrait
Medication Classes Explained Simply
Psychiatric medications can seem like a confusing alphabet soup of SSRIs, SNRIs, and TCAs. However, understanding these classes is simply a matter of understanding what brain chemicals—or neurotransmitters—they target. Think of neurotransmitters as messengers. Depression and anxiety often involve problems with the supply, delivery, or reception of these messages. Each class of medication works by altering these messengers in a specific way.
SSRIs (Selective Serotonin Reuptake Inhibitors)
The Specialists
This is the most commonly prescribed class. SSRIs—including fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), and paroxetine (Paxil)—focus almost exclusively on one neurotransmitter: serotonin. Serotonin is often called the “feel-good” chemical, but it’s more accurately the “stability” chemical, involved in mood, anxiety, sleep, and appetite.
SSRIs work by blocking the “reuptake” of serotonin. In simple terms, when serotonin is released, it’s normally reabsorbed like a sponge soaking up water. SSRIs block the sponge, leaving more serotonin available in the space between neurons. This strengthens the signal. Because they are selective, they have fewer side effects than older drugs, though they can cause sexual dysfunction, nausea, and weight gain.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
The Dual-Action Agents
SNRIs—such as venlafaxine (Effexor), duloxetine (Cymbalta), and desvenlafaxine (Pristiq)—work on two neurotransmitters: serotonin and norepinephrine. Norepinephrine is the brain’s “energy and attention” chemical, linked to alertness, focus, and fight-or-flight response.
By boosting both, SNRIs are often more activating than SSRIs. This makes them particularly useful for depression characterized by fatigue, brain fog, and physical pain. Because they affect two systems, they can have a broader range of side effects, including increased blood pressure (from norepinephrine) and, like SSRIs, sexual side effects.
NDRIs (Norepinephrine-Dopamine Reuptake Inhibitors)
The Motivators
This class is currently represented by a single, popular drug: bupropion (Wellbutrin). Instead of serotonin, it targets norepinephrine and dopamine. Dopamine is the brain’s “reward and motivation” chemical.
Bupropion is unique. Because it doesn’t affect serotonin, it has a very different side effect profile. It rarely causes sexual side effects, weight gain, or sedation. In fact, it can cause weight loss and is activating. However, because it lowers the seizure threshold and can increase anxiety, it’s not suitable for everyone.
TCAs (Tricyclic Antidepressants)
The Broad-Spectrum Tools
TCAs—such as amitriptyline, nortriptyline, and clomipramine—are the older generation. They are “broad-spectrum” agents that increase levels of serotonin and norepinephrine, but they also block several other receptors (histamine, acetylcholine). This makes them very effective but also “dirty”—they cause a wide range of side effects like dry mouth, constipation, sedation, weight gain, and cardiac arrhythmias. They are used today as second- or third-line options, often for treatment-resistant depression or chronic pain.
MAOIs (Monoamine Oxidase Inhibitors)
The Powerful, Risky Classics
MAOIs—such as phenelzine (Nardil) and tranylcypromine (Parnate)—are the oldest class. They work by inhibiting the enzyme monoamine oxidase, which breaks down serotonin, norepinephrine, and dopamine. By preventing this breakdown, they massively increase the levels of all three. They are incredibly potent but come with significant risks, including a dangerous interaction with tyramine (found in aged cheeses, cured meats) that can cause a hypertensive crisis. They are reserved for severe, treatment-resistant cases.
Atypicals
The Multitaskers
“Atypical” is a catch-all term for medications that don’t fit neatly into the other classes. They include mirtazapine (Remeron), which is excellent for insomnia and appetite stimulation, and trazodone, which is now used mostly as a sleep aid. This class also includes newer agents like vortioxetine (Trintellix) and vilazodone (Viibryd), which are serotonin modulators that aim to provide the benefits of SSRIs with fewer sexual side effects.